Related Experiment Video
Updated: May 26, 2026
09:29
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Inflammation in hypertension: current therapeutic approaches
Emmanuel Androulakis1, Dimitris Tousoulis, Nikolaos Papageorgiou
11st Cardiology Unit, Hippokration Hospital, Athens University Medical School, Greece.
Current Pharmaceutical Design
|December 30, 2011
Summary
Inflammation plays a key role in atherosclerosis and hypertension. Measuring inflammatory biomarkers like C-reactive protein can guide treatment and predict outcomes in hypertensive patients.
Area of Science:
- Cardiovascular Science
- Immunology
- Hypertension Research
Background:
- Inflammation is a well-established factor in atherosclerosis development and progression.
- Emerging evidence links essential hypertension to inflammatory processes.
- Elevated inflammatory biomarkers correlate with increased hypertension risk.
Purpose of the Study:
- To explore the association between inflammation and hypertension.
- To highlight the importance of inflammatory markers in managing hypertensive patients.
- To investigate potential anti-inflammatory effects of antihypertensive therapies.
Main Methods:
- Review of existing studies on inflammation and hypertension.
- Analysis of the role of specific inflammatory biomarkers (e.g., C-reactive protein, adhesion molecules, chemokines).
- Discussion of therapeutic implications for hypertensive patients.
Main Results:
- Inflammatory biomarkers are linked to hypertension risk and clinical outcomes.
- Measurement of these markers aids in assessing therapeutic responses.
- Antihypertensive treatments may offer anti-inflammatory benefits.
Conclusions:
- Inflammation is integral to hypertension, influencing risk and progression.
- Monitoring inflammatory markers is crucial for personalized hypertension management.
- Further large-scale studies are needed to confirm anti-inflammatory effects of treatments for arterial hypertension.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...